Genoil Inc. Files 6-K for Q1 2025
Ticker: GNOLF · Form: 6-K · Filed: Jun 2, 2025 · CIK: 1261002
Sentiment: neutral
Topics: sec-filing, 6-K, corporate-update
Related Tickers: GNOLF
TL;DR
Genoil Inc. (GNOLF) filed its Q1 2025 6-K, confirming its reporting status and NY HQ.
AI Summary
Genoil Inc. filed a Form 6-K for the period ending March 31, 2025. The report, filed on June 2, 2025, indicates the company's principal executive office is located at One Rockefeller Plaza, 11th Floor, New York, NY 10020. Genoil Inc. is a foreign private issuer and files annual reports under Form 20-F.
Why It Matters
This filing provides an update on Genoil Inc.'s reporting status and corporate information as of the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a routine periodic filing (6-K) that provides standard corporate information and does not appear to contain significant new financial or operational developments.
Key Numbers
- 000-50766 — Commission File Number (Identifies the company's filing history with the SEC)
Key Players & Entities
- Genoil Inc. (company) — Filer of the report
- 000-50766 (dollar_amount) — Commission File Number
- 20250331 (date) — Period of report
- 20250602 (date) — Filing date
- One Rockefeller Plaza, 11th Floor, New York, NY 10020 (company) — Principal executive office address
FAQ
What is the period of report for this Form 6-K filing?
The period of report is March 31, 2025.
When was this Form 6-K filed with the SEC?
This Form 6-K was filed on June 2, 2025.
What is Genoil Inc.'s principal executive office address?
Genoil Inc.'s principal executive office is located at One Rockefeller Plaza, 11th Floor, New York, NY 10020.
Does Genoil Inc. file its annual reports under Form 20-F or Form 40-F?
Genoil Inc. files its annual reports under cover of Form 20-F.
What is the Commission File Number for Genoil Inc.?
The Commission File Number for Genoil Inc. is 000-50766.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 2, 2025 regarding GENOIL INC (GNOLF).